Two Stocks To Watch For: At Home Group Inc. (NYSE:HOME), Genomic Health, Inc. (NASDAQ:GHDX)

u.s stocks , earnings estimates, stock overview, earning reaction history, nasdaq, nyse

At Home Group Inc. (NYSE:HOME)

At Home Group Inc. (NYSE:HOME) closed at $9.01 on the last trading session with an increase of 5.26%, whereas, it previously closed at $8.56. The company has a market capitalization of $519.61 Million. The company traded shares of 6.76 Million on the trading day while its three month average volume stands at 3.71 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of At Home Group Inc. (NYSE:HOME) produced diluted EPS of 0.98. The EPS estimate for next year as estimated by analysts is at 0.8 while EPS for next quarter is estimated at -0.01. Earnings per Share growth for this year is reported at -4, while the analysts estimated the EPS growth for next year at 0.8% and Earnings growth for next 5 years stands at 14.6% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 31.6%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of At Home Group Inc. (NYSE:HOME) is at 9.2 while the forward p/e is at 11.29. The P/S or Price to Sales ratio of At Home Group Inc. (NYSE:HOME) stands at 0.41 and Price to Book or P/B for the most recent quarter stands at 0.68. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of At Home Group Inc. (NYSE:HOME) are reported at 0.1 and 0.8 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for At Home Group Inc. (NYSE:HOME) stands at 2.9, 8.5 and 5.8 respectively

The trailing twelve month Revenue of At Home Group Inc. (NYSE:HOME) is reported at 1.27 Billion with income of 64.4 Million. The outstanding shares of At Home Group Inc. (NYSE:HOME) are 57.67 Million. The institutional Ownership of the shares of 96.9 stands at 0.80%, this figure is decreased -20.28 in the last six months. The insider ownership for the shares of At Home Group Inc. (NYSE:HOME) is ticked at 0.4%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for At Home Group Inc. (NYSE:HOME) is the Mean Target Price estimated by the analysts which stands at 8.35. The 52 week high of At Home Group Inc. (NYSE:HOME) is placed at 33.97 and 52 week low is standing at 4.58.

Performance wise the shares of At Home Group Inc. (NYSE:HOME) rose up 30.39% for the week, it also rise 88.1% for the monthly performance, while for the quarter it went down 15.81%. The shares decrease -60.38% for the half year and plummeted for the Year-To-Date performance. The shares of At Home Group Inc. (NYSE:HOME) shrinked -72.13% for the yearly performance.

Genomic Health, Inc. (NASDAQ:GHDX)

Genomic Health, Inc. (NASDAQ:GHDX) closed at $72.98 on the last trading session with an increase of 0.51%, whereas, it previously closed at $72.61. The company has a market capitalization of $2.76 Billion. The company traded shares of 352916 on the trading day while its three month average volume stands at 690.5 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Genomic Health, Inc. (NASDAQ:GHDX) produced diluted EPS of 1.32. The EPS estimate for next year as estimated by analysts is at 1.67 while EPS for next quarter is estimated at 0.37. Earnings per Share growth for this year is reported at 725.8, while the analysts estimated the EPS growth for next year at 1.67% and Earnings growth for next 5 years stands at 22.55% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 29.7%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Genomic Health, Inc. (NASDAQ:GHDX) is at 55.5 while the forward p/e is at 43.65. The P/S or Price to Sales ratio of Genomic Health, Inc. (NASDAQ:GHDX) stands at 6.44 and Price to Book or P/B for the most recent quarter stands at 8.55. The Price to Free Cash Flow ratio or P/FCF is reported at 37.88. The quick ratio and the current ratio of Genomic Health, Inc. (NASDAQ:GHDX) are reported at 5.7 and 5.7 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Genomic Health, Inc. (NASDAQ:GHDX) stands at 13.8, 17.9 and 8.6 respectively

The trailing twelve month Revenue of Genomic Health, Inc. (NASDAQ:GHDX) is reported at 428.8 Million with income of 50.7 Million. The outstanding shares of Genomic Health, Inc. (NASDAQ:GHDX) are 37.84 Million. The institutional Ownership of the shares of 96.8 stands at 0.80%, this figure is increased 0.39 in the last six months. The insider ownership for the shares of Genomic Health, Inc. (NASDAQ:GHDX) is ticked at 0.7%, the figure is plummeted -89.53% in the last six months.

Some other important financial aspects to be discussed here for Genomic Health, Inc. (NASDAQ:GHDX) is the Mean Target Price estimated by the analysts which stands at 70.71. The 52 week high of Genomic Health, Inc. (NASDAQ:GHDX) is placed at 92.18 and 52 week low is standing at 50.77.

Performance wise the shares of Genomic Health, Inc. (NASDAQ:GHDX) fell down -2.91% for the week, it also fell -0.19% for the monthly performance, while for the quarter it went down 39.3%. The shares decrease -3.97% for the half year and flew up for the Year-To-Date performance. The shares of Genomic Health, Inc. (NASDAQ:GHDX) grew 14.16% for the yearly performance.

You may missed